Pathogenesis and risk factors for gastric cancer after Helicobacter pylori eradication

doi:10.4251/wjgo.v8.i9.663

Advanced Search

BPG is committed to discovery and dissemination of knowledge

Home / Archive / Volume 8, Issue 9

This Article

Academic Content and Language Evaluation of This Article

CrossCheck and Google Search of This Article

Academic Rules and Norms of This Article

Citation of this article

Corresponding Author of This Article

Research Domain of This Article

Article-Type of This Article

Open-Access Policy of This Article

Times Cited Counts in Google of This Article

Number of Hits and Downloads for This Article

Total Article Views (8489)

All Articles published online

The chart showing PDF series, WORD series, HTML series, Figures (1-1) series.

Item

Count

PDF

661

WORD

377

HTML

4760

Figures (1-1)

212

Sum=6010

Publishing Process of This Article

The chart showing Browse series, Download series.

Item

Count

Browse

1062

Download

1417

Sum=2479

Sep 15, 2016 (publication date) through Nov 5, 2024

Times Cited of This Article

Times Cited (12)

Journal Information of This Article

Publication Name

World Journal of Gastrointestinal Oncology

ISSN

1948-5204

Publisher of This Article

Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA

Review

World J Gastrointest Oncol. Sep 15, 2016; 8(9): 663-672
Published online Sep 15, 2016. doi: 10.4251/wjgo.v8.i9.663

Full Size Figure Download Figure

Figure 1 Relationship between gastric mucosae methylation levels and Helicobacter pylori infection/gastric cancer (modified from Maekita et al[22]). Residual aberrant methylation even after eradication is thought to reflect methylation in gastric gland stem cells. From endoscopically biopsied tissue, predicting GC risk based on the accumulation of aberrant DNA methylation in the gastric mucosae. ESD: Endoscopic submucosal resection; GC: Gastric cancer; H. pylori: Helicobacter pylori.

Citation: Ohba R, Iijima K. Pathogenesis and risk factors for gastric cancer after Helicobacter pylori eradication. World J Gastrointest Oncol 2016; 8(9): 663-672
URL: https://www.wjgnet.com/1948-5204/full/v8/i9/663.htm
DOI: https://dx.doi.org/10.4251/wjgo.v8.i9.663